Immune cells associated with security against COVID-19 recognized Kumar Jeetendra | June 27, 2020 Patients experiencing extreme respiratory indications because of the novel coronavirus disease can quickly create a safe reaction as infection assaulting T cells, recommends another examination which may prompt new immunization improvement methodologies against COVID-19. The examination, distributed in the diary Science Immunology, surveyed T cells from 10 COVID-19 patients under escalated care treatment. As indicated …
“Genome Editing of Immune Cells” – New Lonza Virtual Event Kumar Jeetendra | September 14, 2022 Basel, Switzerland, 06 September 2022 – On September 20, 2022, Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery. The 3-hour workshop brings together renowned genome editing experts from across industry and academia and comprises four interactive speaker sessions and a concluding panel discussion. …
